Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC.
Ge C, Li R, Song H, Geng T, Yang J, Tan Q, Song L, Wang Y, Xue Y, Li Z, Dong S, Zhang Z, Zhang N, Guo J, Hua L, Chen S, Song X.
Ge C, et al. Among authors: zhang n, zhang z.
BMC Cancer. 2017 Dec 21;17(1):884. doi: 10.1186/s12885-017-3859-3.
BMC Cancer. 2017.
PMID: 29268708
Free PMC article.
Clinical Trial.